Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTBL
3626
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
| $368K | ﹤0.01% |
81,805
+64,988
| +386% | +$326K |
|
3627
Thor Industries
THO
$4.14B
| $367K | ﹤0.01% |
6,559
-6,781
| -51% | -$410K |
|
3628
CALL
AngloGold Ashanti
AU
$48.7B
| $366K | ﹤0.01% |
45,700
-5,900
| -11% | -$59.9K |
|
3629
PUT
Snap-on
SNA
$21.5B
| $366K | ﹤0.01% |
2,300
-3,300
| -59% | -$509K |
|
|
TESO
3630
DELISTED
Tesco Corp
TESO
| $366K | ﹤0.01% |
36,620
+35,581
| +3,425% | +$427K |
|
|
SAGE
3631
PUT
DELISTED
Sage Therapeutics
SAGE
| $365K | ﹤0.01% |
+5,000
| New | +$321K |
|
3632
CALL
ProShares UltraShort QQQ
QID
$247M
| $364K | ﹤0.01% |
130
-434
| -77% | -$1.2M |
|
3633
Carter's
CRI
$1.47B
| $363K | ﹤0.01% |
3,424
+1,589
| +87% | +$159K |
|
3634
PUT
ProShares UltraShort Energy
DUG
$22M
| $362K | ﹤0.01% |
335
-1,245
| -79% | -$1.24M |
|
3635
CALL
Flex
FLEX
$44.8B
| $362K | ﹤0.01% |
43,658
-15,526
| -26% | -$143K |
|
|
TBHC
3636
DELISTED
The Brand House Collective
TBHC
| $362K | ﹤0.01% |
13,418
+7,925
| +144% | +$199K |
|
3637
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
| $362K | ﹤0.01% |
6,710
-2,700
| -29% | -$150K |
|
|
PRAH
3638
DELISTED
PRA Health Sciences, Inc.
PRAH
| $362K | ﹤0.01% |
10,055
+9,470
| +1,619% | +$300K |
|
|
ATML
3639
PUT
DELISTED
ATMEL CORP
ATML
| $362K | ﹤0.01% |
40,200
+14,600
| +57% | +$129K |
|
|
KNGT
3640
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $362K | ﹤0.01% |
13,944
+7,616
| +120% | +$198K |
|
|
BRLI
3641
PUT
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $361K | ﹤0.01% |
8,800
-11,200
| -56% | -$402K |
|
3642
PUT
Ameriprise Financial
AMP
$48.8B
| $360K | ﹤0.01% |
2,900
+1,300
| +81% | +$166K |
|
3643
FNB Corp
FNB
$6.75B
| $360K | ﹤0.01% |
25,678
+5,377
| +26% | +$72.9K |
|
|
GES
3644
CALL
DELISTED
Guess Inc
GES
| $359K | ﹤0.01% |
18,900
-11,800
| -38% | -$222K |
|
3645
PUT
Sturm, Ruger & Co
RGR
$593M
| $359K | ﹤0.01% |
6,300
-1,100
| -15% | -$59.9K |
|
|
N
3646
DELISTED
Netsuite Inc
N
| $358K | ﹤0.01% |
3,935
+650
| +20% | +$61.6K |
|
|
COBZ
3647
DELISTED
CoBiz Financial,Inc
COBZ
| $358K | ﹤0.01% |
27,560
+26,485
| +2,464% | +$325K |
|
3648
Vail Resorts
MTN
$5.3B
| $356K | ﹤0.01% |
3,264
-17,306
| -84% | -$1.81M |
|
|
OREX
3649
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $356K | ﹤0.01% |
8,890
+1,310
| +17% | +$78.3K |
|
3650
EnerSys
ENS
$6.99B
| $355K | ﹤0.01% |
5,062
-70
| -1% | -$4.8K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.